Hikal Ltd (NSE:HIKAL)
₹ 217.99 +1.64 (+0.76%) Market Cap: 26.87 Bil Enterprise Value: 33.25 Bil PE Ratio: 0 PB Ratio: 2.24 GF Score: 73/100

Q4 2026 Hikal Ltd Earnings Call Transcript

May 27, 2026 / 12:00 PM GMT
Release Date Price: ₹221.32 (+1.50%)

Key Points

Positve
  • Hikal Ltd (BOM:524735) reported a significant improvement in EBITDA margins to 20.3% in Q4 2026, indicating enhanced operational efficiency.
  • The company has made strategic investments in new facilities, such as a high-potency laboratory and expanded R&D infrastructure, which are now operational and strengthening its position in complex chemistries.
  • Hikal Ltd (BOM:524735) is witnessing favorable demand trends in its pharmaceutical business, particularly in the API and CDMO segments, supported by increased outsourcing opportunities.
  • The crop protection business showed recovery in Q4 2026, driven by improved customer volumes and normalization in the global agrochemical value chain.
  • The animal health business is gaining momentum with increasing global outsourcing activity and customer engagement, positioning it as a long-term growth driver for the company.
Negative
  • Hikal Ltd (BOM:524735) faced a setback due to a US FDA warning letter, impacting its pharmaceutical business and causing a slowdown in production activities.
  • The company reported a negative PAT of Rs. 79.3 crore for FY 2026, affected by exceptional items related to impairment charges.
  • There is ongoing pricing pressure in the crop protection segment, with no significant price increases from Chinese manufacturers despite raw material cost escalations.
  • The company has experienced flat or negative growth over the past three years, with challenges in achieving its historical growth targets.
  • Hikal Ltd (BOM:524735) is facing uncertainties due to geopolitical factors affecting raw material costs and logistics, impacting short-term financial performance.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

HIKA.NS - Hikal Ltd
Q4 2026 Hikal Ltd Earnings Call
May 27, 2026 / 12:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, good day and welcome to the Q4 and FY26 earnings conference call of Heikel Limited.

This conference call will contain forward-looking statements about the company which are based on beliefs, opinions and expectations the company has on date of this call.

These statements are not the guarantees of future performance and involve risk and uncertainties that are difficult to predict.

As a reminder, all participant lines will be in a listen-only mode, and there will be an opportunity for you to ask questions after the presentation concludes.

Should you need assistance during the conference call, please signal an operator by pressing *, then 0 on your touchtone phone.

I now hand the
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot